In Vivo Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials.
Selle K, Fletcher JR, Tuson H, Schmitt DS, McMillan L, Vridhambal GS, Rivera AJ, Montgomery SA, Fortier LC, Barrangou R, Theriot CM, Ousterout DG.
Selle K, et al. Among authors: rivera aj.
mBio. 2020 Mar 10;11(2):e00019-20. doi: 10.1128/mBio.00019-20.
mBio. 2020.
PMID: 32156803
Free PMC article.